Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 101 results found. Search for [ booster dose ]

Results 1 to 21 of 101
PTI
June 19, 2021
Professor Andrew Pollard noted that in India, the vast majority of the population is unvaccinated and, therefore, unprotected at a time when the Delta variant is a widespread and increasing threat


Anand Adhikari
New Delhi, June 9, 2021
From disrupters to partners, the Fintech-bank relationship has come a long way. What is the next level of this partnership?


Reuters
June 5, 2021
China's mass vaccination drive, which administered 723.5 million doses of vaccines as of June 3, is currently only open to those aged 18 and above


PTI
June 1, 2021
Researchers at the Rockefeller University in the US analysed antibodies present in the blood of Covid patients, tracking the evolution of these molecules


BusinessToday.In
June 1, 2021
Mahindra believes that a substantial supply of a variety of vaccines made around the world is \"our only true defense against a third-- and all future-- waves\"


PTI
June 1, 2021
Cipla has said such an assurance will help make this significant financial commitment of more than $1 billion (over Rs 7,250 crore) advance to Moderna for its booster vaccine in India


Reuters
May 25, 2021
The aim of the study is to understand if the combination of the vaccines is safe, and the immune response after adding the pneumonia vaccine to the existing COVID-19 vaccine, Pfizer said


BusinessToday.In
May 22, 2021
The discussion note co-authored by IMF chief economist Gita Gopinath and staff economist Ruchir Agarwal also endorsed centralised procurement by the Centre and backed deferring the second dose as far as possible


Reuters
May 21, 2021
Doing so, IMF officials say, would inject the equivalent of $9 trillion into the global economy by 2025 due to a faster resumption of economic activity, with rich countries potentially benefiting the most


PTI
May 18, 2021
The government last week extended the gap between two doses of the Covishield COVID-19 vaccine to 12-16 weeks, up from the previous maximum of eight weeks, on the recommendation of the NTAGI


PTI
May 16, 2021
Moderna has been widely used in countries such as Canada, United States and the United Kingdom under emergency use authorisations granted by these countries and the World Health Organisation.


Reuters
May 14, 2021
The Russian Direct Investment Fund (RDIF), which is responsible for marketing the vaccine abroad, said the manufacturing capacity for Sputnik V was increasing globally as new manufacturers come on board.


Reuters
May 8, 2021
The UK has administered over 51 million vaccines and has been the second quickest country to give a first dose to at least half its adult population


Reuters
April 23, 2021
The vaccines from the U.S. drugmaker and its German partner BioNTech would be delivered over 2021-2023, Commission President Ursula von der Leyen said during a visit to Pfizer's vaccine plant in Puurs, Belgium


Reuters
April 19, 2021
The South African variant, B.1.351, was found to make up about 1% of all the COVID-19 cases across all the people studied, according to the study by Tel Aviv University and Israel's largest healthcare provider, Clalit


PTI
April 18, 2021
India is battling a massive surge in COVID-19 cases and health ministry data updated on Sunday showed that a record single-day rise of 2,61,500 coronavirus infections has taken the country's total tally to 1,47,88,109


BusinessToday.In
April 16, 2021
\"It is extremely important to suppress the pool of people that can be susceptible to the virus,\" said Pfizer CEO Albert Bourla


Reuters
April 10, 2021
A follow-up study of 33 people who received Moderna Inc's COVID-19 vaccine in early trials show the antibodies it induced are still present six months after the second dose


BusinessToday.In
April 2, 2021
A subject expert committee (SEC) of the DCGI has allowed Bharat Biotech to give the third dose of Covaxin to a few volunteers six months after the second dose


Reuters
March 16, 2021
The Pennsylvania-based biopharmaceutical firm is partnering with India's Bharat Biotech, a developer of the vaccine, to commercialize the shot in the United States


PAGES 1 OF 6  12345